Contents
Academic literature on the topic 'Radioembolisation hépatique'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Radioembolisation hépatique.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Radioembolisation hépatique"
Vesselle, G., I. Petit, S. Boucebci, T. Rocher, S. Velasco, and J. P. Tasu. "Radioembolisation hépatique à l’Yttrium-90 : guide pratique et revue de littérature." Journal de Radiologie Diagnostique et Interventionnelle 96, no. 2 (June 2015): 119–34. http://dx.doi.org/10.1016/j.jradio.2014.01.012.
Full textPernot, S., O. Pellerin, N. Ghazzar, J. N. Vaillant, C. Lepère, M. Sapoval, J. Taieb, and P. Rougier. "Chimiothérapie intra-artérielle hépatique, chimioembolisation et radioembolisation : un apport important pour le traitement des métastases hépatiques des cancers colorectaux." Oncologie 16, no. 11-12 (December 2014): 571–78. http://dx.doi.org/10.1007/s10269-014-2468-x.
Full textLenoir, L., J. Edeline, Y. Rolland, H. Mesbah, P. Poree, S. Laffont, M. Pracht, V. Ardisson, E. Boucher, and E. Garin. "Radioembolisation du CHC : prédiction de la réponse et de la survie par la scintigraphie de perfusion hépatique (TEMP/TDM) aux MAA-99mTc." Médecine Nucléaire 36, no. 4 (April 2012): 166. http://dx.doi.org/10.1016/j.mednuc.2012.02.032.
Full textIlonca, A. D., M. Fourcade, D. De Verbizier Lonjon, E. Delhom, B. Guiu, and D. Mariano Goulart. "Radioembolisation hépatique en vue d’une lobectomie radique à l’aide des microsphères en résine chargées en Y90 pour un hépatocarcinome avec thrombose portale droite tumorale." Médecine Nucléaire 40, no. 3 (May 2016): 195. http://dx.doi.org/10.1016/j.mednuc.2016.03.071.
Full textLenoir, L., Y. Rolland, S. Laffont, V. Ardisson, E. Boucher, J. L. Raoul, and E. Garin. "Radioembolisation des tumeurs hépatiques par microsphères marquées à l’yttrium-90." Médecine Nucléaire 35, no. 4 (April 2011): 224–31. http://dx.doi.org/10.1016/j.mednuc.2011.02.013.
Full textRoux, J., L. Djaïleb, M. D. Desruet, C. Gallazzini-Crepin, and J. P. Vuillez. "Quelle place pour la radioembolisation Yttrium 90 dans le traitement des métastases hépatiques du cancer colorectal ?" Médecine Nucléaire 40, no. 6 (November 2016): 416–19. http://dx.doi.org/10.1016/j.mednuc.2016.09.003.
Full textSchaefer, NG, and T. Pfammatter. "Radioembolisation transartérielle des carcinomes hépatiques par sphères de résine Y-90 (sphères SIR)." Forum Médical Suisse ‒ Swiss Medical Forum 10, no. 41 (October 13, 2010). http://dx.doi.org/10.4414/fms.2010.07307.
Full textDissertations / Theses on the topic "Radioembolisation hépatique"
Hammami, Houda. "Guidance of radioembolization procedures in the context of interventional oncology." Thesis, Rennes 1, 2021. http://www.theses.fr/2021REN1S121.
Full textRadioembolization is a minimally-invasive intervention performed to treat liver cancer by administering radioactive microspheres. In order to optimize radioembolization outcomes, the procedure is carried out in two sessions: pretreatment assessment intervention, mainly performed to locate the injection site, assess microspheres distribution and perform dosimetry evaluation, and treatment intervention performed to inject the estimated proper dose of radioactive microspheres in the located injection site. Due to the hepatic vasculature complexity, interventional radiologists carefully manipulate the catheter, during the two interventions, under X-Ray image guidance and resort to contrast media injection in order to highlight vessels. In this thesis, we propose a novel guidance strategy that promises a simplification and accuracy of the catheter navigation during the pretreatment assessment, as well as during the treatment interventions. The proposed navigation system processes pre- and intraoperative images to achieve intraoperative image fusion through a rigid registration technique. This approach is designed to 1) assist the celiac trunk access, 2) assist the injection site access and 3) automatically reproduce the injection site during the proper intervention. Knowing that the liver undergoes a motion induced by the breathing, we also propose an approach that allows obtaining a dynamic overlay of the projected 3D vessels onto fluoroscopy
Verger, Elise. "Microparticules à base d’amidon (SBMP) comme agent théranostique unique pour la radiothérapie sélective interne des tumeurs hépatiques : radiomarquage au gallium-68 et rhénium-188 et étude préliminaire in vivo." Thesis, Angers, 2016. http://www.theses.fr/2016ANGE0054/document.
Full textThe Hepatocellular Carcinoma has a high incidence worldwide and is associated with a bad prognostic. The existing curative treatments can only be apply in a minority of cases. The selective internal radiation therapy (SIRT) is a palliative treatment that is increasingly used. This technique is define by the selective intratumoral injection of yttrium-90microspheres via intra-arterial infusion. It involves two steps : a pre-therapeutic one for treatment simulation purpose with the injection of serum albumin macroaggregates radiolabeled with 99mTc and the treatment itself. However the characteristics of these two vectors are different and can lead to variations in biodistribution and approximate dosimetry. This works aims to develop a unique radiotheranostic vector for the SIRT: the starch-basedmicroparticles (SBMP), in order to overcome the different currents clinical problems. The optimization of the radiolabeling by the 68Ga and the 188Re in the form of ready-to-use radiolabeling kits allowed to obtain a radiochemical purity > 98 % and > 95 % respectively. A preliminary in vivo study by PET/CT imaging in rat, following the intra-arterial injection of 68Ga-SBMP displayed a specific biodistribution of the microparticles with more than 95 % of the activity found in the liver and mostly in the tumors. The SBMP offer several advantages that answer different current issues and area promising theranostic agent for the SIRT. A presentation of the SIRT, the different microparticles in development and the existing animal models of hepatic tumor will also be developed in this work